- Home
- MHUA vs INBS Comparison
MHUA vs INBS Comparison
Compare MHUA & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHUA
- INBS
- Stock Information
- Founded
- MHUA 1990
- INBS 2016
- Country
- MHUA China
- INBS United States
- Employees
- MHUA N/A
- INBS N/A
- Industry
- MHUA Medical Specialities
- INBS Medical Specialities
- Sector
- MHUA Health Care
- INBS Health Care
- Exchange
- MHUA Nasdaq
- INBS Nasdaq
- Market Cap
- MHUA 11.8M
- INBS 11.7M
- IPO Year
- MHUA 2022
- INBS N/A
- Fundamental
- Price
- MHUA $0.46
- INBS $1.79
- Analyst Decision
- MHUA
- INBS
- Analyst Count
- MHUA 0
- INBS 0
- Target Price
- MHUA N/A
- INBS N/A
- AVG Volume (30 Days)
- MHUA 132.7K
- INBS 124.8K
- Earning Date
- MHUA 09-19-2025
- INBS 11-06-2025
- Dividend Yield
- MHUA N/A
- INBS N/A
- EPS Growth
- MHUA N/A
- INBS N/A
- EPS
- MHUA 0.40
- INBS N/A
- Revenue
- MHUA $96,909,642.00
- INBS $3,052,532.00
- Revenue This Year
- MHUA N/A
- INBS $778.48
- Revenue Next Year
- MHUA N/A
- INBS N/A
- P/E Ratio
- MHUA $1.07
- INBS N/A
- Revenue Growth
- MHUA N/A
- INBS N/A
- 52 Week Low
- MHUA $0.25
- INBS $1.10
- 52 Week High
- MHUA $1.24
- INBS $2.75
- Technical
- Relative Strength Index (RSI)
- MHUA 65.24
- INBS 62.21
- Support Level
- MHUA $0.35
- INBS $1.65
- Resistance Level
- MHUA $0.46
- INBS $1.78
- Average True Range (ATR)
- MHUA 0.04
- INBS 0.11
- MACD
- MHUA 0.00
- INBS 0.03
- Stochastic Oscillator
- MHUA 73.33
- INBS 92.86
About MHUA Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).